| Literature DB >> 27519939 |
Licínio Manco1, Celeste Bento2, Bruno L Victor3, Janet Pereira4, Luís Relvas4, Rui M Brito5, Carlos Seabra6, Tabita M Maia7, M Letícia Ribeiro2.
Abstract
Glucose-6-phosphate isomerase (GPI) deficiency cause hereditary nonspherocytic hemolytic anemia (HNSHA) of variable severity in individuals homozygous or compound heterozygous for mutations in GPI gene. This work presents clinical features and genotypic results of two patients of Portuguese origin with GPI deficiency. The patients suffer from a mild hemolytic anemia (Hb levels ranging from 10 to 12.7g/mL) associated with macrocytosis, reticulocytosis, hyperbilirubinemia, hyperferritinemia and slight splenomegaly. Genomic DNA sequencing revealed in one patient homozygosity for a new missense mutation in exon 3, c.260G>C (p.Gly87Ala), and in the second patient compound heterozygosity for the same missense mutation (p.Gly87Ala), along with a frameshift mutation resulting from a single nucleotide deletion in exon 14, c.1238delA (p.Gln413Arg fs*24). Mutation p.Gln413Arg fs*24 is the first frameshift null mutation to be described in GPI deficiency. Molecular modeling suggests that the structural change induced by the p.Gly87Ala pathogenic variant has direct impact in the structural arrangement of the region close to the active site of the enzyme.Entities:
Keywords: GPI deficiency; Glucose-6-phosphate isomerase (GPI); Glycolysis; Hemolytic anemia; Portugal
Mesh:
Substances:
Year: 2016 PMID: 27519939 DOI: 10.1016/j.bcmd.2016.06.002
Source DB: PubMed Journal: Blood Cells Mol Dis ISSN: 1079-9796 Impact factor: 3.039